nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A hundred days: what is to show for it?
|
The Lancet, |
|
2017 |
389 |
10080 |
p. 1669- 1 p. |
artikel |
2 |
Better understanding of youth mental health
|
The Lancet, |
|
2017 |
389 |
10080 |
p. 1670- 1 p. |
artikel |
3 |
Computerised cardiotocography—study design hampers findings
|
Belfort, Michael A |
|
2017 |
389 |
10080 |
p. 1674-1676 3 p. |
artikel |
4 |
Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial
|
|
|
2017 |
389 |
10080 |
p. 1719-1729 11 p. |
artikel |
5 |
Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study
|
Kaplan, Hillard |
|
2017 |
389 |
10080 |
p. 1730-1739 10 p. |
artikel |
6 |
Crohn's disease
|
Torres, Joana |
|
2017 |
389 |
10080 |
p. 1741-1755 15 p. |
artikel |
7 |
Department of Error
|
|
|
2017 |
389 |
10080 |
p. 1698- 1 p. |
artikel |
8 |
From arterial ageing to cardiovascular disease
|
Koopman, Jacob J E |
|
2017 |
389 |
10080 |
p. 1676-1678 3 p. |
artikel |
9 |
Grey-market medicines: diphtheria antitoxin and the decay of biomedical infrastructure
|
Vargha, Dora |
|
2017 |
389 |
10080 |
p. 1690-1691 2 p. |
artikel |
10 |
Health an afterthought in a single-issue election
|
The Lancet, |
|
2017 |
389 |
10080 |
p. 1670- 1 p. |
artikel |
11 |
Health professional associations and industry funding—reply from Forsyth
|
Forsyth, Stewart |
|
2017 |
389 |
10080 |
p. 1694-1695 2 p. |
artikel |
12 |
Health professional associations and industry funding—reply from Modi et al
|
Modi, Neena |
|
2017 |
389 |
10080 |
p. 1693-1694 2 p. |
artikel |
13 |
Health professional associations and industry funding—reply from O'Brien
|
O'Brien, Declan |
|
2017 |
389 |
10080 |
p. 1694- 1 p. |
artikel |
14 |
Health professional associations and industry funding—reply from Parry et al
|
Parry, Kathleen C |
|
2017 |
389 |
10080 |
p. 1696- 1 p. |
artikel |
15 |
Health professional associations and industry funding—reply from Savage
|
Savage, Felicity |
|
2017 |
389 |
10080 |
p. 1696- 1 p. |
artikel |
16 |
Health professional associations and industry funding—reply from Talukder et al
|
Talukder, Muhammad Qudrat-e-Khuda |
|
2017 |
389 |
10080 |
p. 1696-1697 2 p. |
artikel |
17 |
Health professional associations and industry funding—reply from Waterston et al
|
Waterston, Tony |
|
2017 |
389 |
10080 |
p. 1695- 1 p. |
artikel |
18 |
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|
Feagan, Brian G |
|
2017 |
389 |
10080 |
p. 1699-1709 11 p. |
artikel |
19 |
Kenneth Joseph Arrow
|
Watts, Geoff |
|
2017 |
389 |
10080 |
p. 1692- 1 p. |
artikel |
20 |
Marching for science as budget cuts threaten US research
|
Jaffe, Susan |
|
2017 |
389 |
10080 |
p. 1683-1684 2 p. |
artikel |
21 |
May Measurement Month: a global blood pressure screening campaign
|
Poulter, Neil R |
|
2017 |
389 |
10080 |
p. 1678-1680 3 p. |
artikel |
22 |
Medication Without Harm: WHO's Third Global Patient Safety Challenge
|
Donaldson, Liam J |
|
2017 |
389 |
10080 |
p. 1680-1681 2 p. |
artikel |
23 |
Nelly Mugo—rolling out PrEP in Kenya
|
Kirby, Tony |
|
2017 |
389 |
10080 |
p. 1689- 1 p. |
artikel |
24 |
Non-healing ulcerative paronychia
|
Jack, Carolyn |
|
2017 |
389 |
10080 |
p. 1740- 1 p. |
artikel |
25 |
Offline: The new neglected (non-tropical) diseases
|
Horton, Richard |
|
2017 |
389 |
10080 |
p. 1682- 1 p. |
artikel |
26 |
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|
Kugathasan, Subra |
|
2017 |
389 |
10080 |
p. 1710-1718 9 p. |
artikel |
27 |
Profile: INS in Bogotá—100 years improving Colombian health
|
Rubin, Rita |
|
2017 |
389 |
10080 |
p. 1686- 1 p. |
artikel |
28 |
Rising violence against health workers in India
|
Sharma, Dinesh C |
|
2017 |
389 |
10080 |
p. 1685- 1 p. |
artikel |
29 |
RISK stratification in paediatric Crohn's disease
|
Arijs, Ingrid |
|
2017 |
389 |
10080 |
p. 1672-1674 3 p. |
artikel |
30 |
Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient
|
Hanauer, Stephen B |
|
2017 |
389 |
10080 |
p. 1671-1672 2 p. |
artikel |
31 |
The INFANT study—a flawed design foreseen
|
Keith, Robert |
|
2017 |
389 |
10080 |
p. 1697-1698 2 p. |
artikel |
32 |
Thomas Browne: a rarity among rarities
|
Ferry, Georgina |
|
2017 |
389 |
10080 |
p. 1687-1688 2 p. |
artikel |
33 |
Ulcerative colitis
|
Ungaro, Ryan |
|
2017 |
389 |
10080 |
p. 1756-1770 15 p. |
artikel |
34 |
What can WHO do to support research in LMICs?
|
Belizán, José M |
|
2017 |
389 |
10080 |
p. 1697- 1 p. |
artikel |